These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 11870371)
1. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump. Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371 [TBL] [Abstract][Full Text] [Related]
2. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters. Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018 [TBL] [Abstract][Full Text] [Related]
3. Bile salt excretory pump: biology and pathobiology. Suchy FJ; Ananthanarayanan M J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395 [TBL] [Abstract][Full Text] [Related]
4. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. Ananthanarayanan M; Balasubramanian N; Makishima M; Mangelsdorf DJ; Suchy FJ J Biol Chem; 2001 Aug; 276(31):28857-65. PubMed ID: 11387316 [TBL] [Abstract][Full Text] [Related]
5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related]
6. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830 [TBL] [Abstract][Full Text] [Related]
7. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. Kassam A; Miao B; Young PR; Mukherjee R J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787 [TBL] [Abstract][Full Text] [Related]
8. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824 [TBL] [Abstract][Full Text] [Related]
9. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. Deng R; Yang D; Yang J; Yan B J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446 [TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. Chiang JY; Kimmel R; Weinberger C; Stroup D J Biol Chem; 2000 Apr; 275(15):10918-24. PubMed ID: 10753890 [TBL] [Abstract][Full Text] [Related]
11. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1. Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749 [TBL] [Abstract][Full Text] [Related]
12. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519 [TBL] [Abstract][Full Text] [Related]
13. Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor. Jung D; Podvinec M; Meyer UA; Mangelsdorf DJ; Fried M; Meier PJ; Kullak-Ublick GA Gastroenterology; 2002 Jun; 122(7):1954-66. PubMed ID: 12055601 [TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. Huang L; Zhao A; Lew JL; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Royo I; Blevins RA; Peláez F; Wright SD; Cui J J Biol Chem; 2003 Dec; 278(51):51085-90. PubMed ID: 14527955 [TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. Honjo Y; Sasaki S; Kobayashi Y; Misawa H; Nakamura H J Endocrinol; 2006 Mar; 188(3):635-43. PubMed ID: 16522742 [TBL] [Abstract][Full Text] [Related]
16. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500 [TBL] [Abstract][Full Text] [Related]
17. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter. Neimark E; Chen F; Li X; Shneider BL Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098 [TBL] [Abstract][Full Text] [Related]
18. The amino acid residues asparagine 354 and isoleucine 372 of human farnesoid X receptor confer the receptor with high sensitivity to chenodeoxycholate. Cui J; Heard TS; Yu J; Lo JL; Huang L; Li Y; Schaeffer JM; Wright SD J Biol Chem; 2002 Jul; 277(29):25963-9. PubMed ID: 12004058 [TBL] [Abstract][Full Text] [Related]
19. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation. Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573 [TBL] [Abstract][Full Text] [Related]
20. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis. Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]